103 related articles for article (PubMed ID: 34424323)
1. B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations.
Six KA; Gerdemann U; Brown AL; Place AE; Cantor AB; Kutny MA; Avagyan S
Blood Adv; 2021 Aug; 5(16):3199-3202. PubMed ID: 34424323
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy.
Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
Blood Adv; 2024 Jan; 8(2):497-511. PubMed ID: 38019014
[TBL] [Abstract][Full Text] [Related]
3. Genomic Landscape of Patients with Germline
Yu K; Deuitch N; Merguerian M; Cunningham L; Davis J; Bresciani E; Diemer J; Andrews E; Young A; Donovan F; Sood R; Craft K; Chong S; Chandrasekharappa S; Mullikin J; Liu PP
bioRxiv; 2023 Jan; ():. PubMed ID: 36789433
[TBL] [Abstract][Full Text] [Related]
4. Natural history study of patients with familial platelet disorder with associated myeloid malignancy.
Cunningham L; Merguerian M; Calvo KR; Davis J; Deuitch NT; Dulau-Florea A; Patel N; Yu K; Sacco K; Bhattacharya S; Passi M; Ozkaya N; De Leon S; Chong S; Craft K; Diemer J; Bresciani E; O'Brien K; Andrews EJ; Park N; Hathaway L; Cowen EW; Heller T; Ryan K; Barochia A; Nghiem K; Niemela J; Rosenzweig S; Young DJ; Frischmeyer-Guerrerio PA; Braylan R; Liu PP
Blood; 2023 Dec; 142(25):2146-2158. PubMed ID: 37738626
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing familial platelet disorder with predisposition to myeloid malignancy: Lessons learned from a germline whole-gene deletion of RUNX1.
Cliburn JA; Uy JC; Swift S; Liesveld JL; Iqbal MA; Jajosky AN; Becker MW
Int J Lab Hematol; 2024 Feb; 46(1):203-206. PubMed ID: 37953439
[No Abstract] [Full Text] [Related]
6. Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice.
Ahmad MH; Hegde M; Wong WJ; Mohammadhosseini M; Garrett L; Carrascoso A; Issac N; Ebert B; Silva JC; Pihan G; Zhu LJ; Wolfe SA; Agarwal A; Liu PP; Castilla LH
Blood Adv; 2023 Dec; 7(23):7304-7318. PubMed ID: 37756546
[TBL] [Abstract][Full Text] [Related]
7. A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies.
Lee BC; Zhou Y; Bresciani E; Ozkaya N; Dulau-Florea A; Carrington B; Shin TH; Baena V; Syed ZA; Hong SG; Zhen T; Calvo KR; Liu P; Dunbar CE
Blood; 2023 Jan; 141(3):231-237. PubMed ID: 36322931
[TBL] [Abstract][Full Text] [Related]
8. The clinical heterogeneity of
Tang C; Rabbolini DJ; Morel-Kopp MC; Connor DE; Crispin P; Ward CM; Stevenson WS
Res Pract Thromb Haemost; 2020 Jan; 4(1):106-110. PubMed ID: 31989091
[TBL] [Abstract][Full Text] [Related]
9. Seeding the future: the natural history of RUNX1 deficiency.
Ripperger T
Blood; 2023 Dec; 142(25):2127-2128. PubMed ID: 38127412
[No Abstract] [Full Text] [Related]
10. The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.
Zanetti C; Kumar R; Ender J; Godavarthy PS; Hartmann M; Hey J; Breuer K; Weissenberger ES; Minciacchi VR; Karantanou C; Gu Z; Roberts KG; Metzler M; Stock W; Mullighan CG; Bloomfield CD; Filmann N; Bankov K; Hartmann S; Hasserjian RP; Cousins AF; Halsey C; Plass C; Lipka DB; Krause DS
Blood; 2021 Nov; 138(19):1870-1884. PubMed ID: 34424946
[TBL] [Abstract][Full Text] [Related]
11. Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification.
van der Werf I; Wojtuszkiewicz A; Meggendorfer M; Hutter S; Baer C; Heymans M; Valk PJM; Kern W; Haferlach C; Janssen JJWM; Ossenkoppele GJ; Cloos J; Haferlach T
Blood Adv; 2021 Sep; 5(17):3254-3265. PubMed ID: 34448812
[TBL] [Abstract][Full Text] [Related]
12. To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition.
Avagyan S; Brown AL
J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623329
[TBL] [Abstract][Full Text] [Related]
13. Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Thudium Mueller K; Grupp SA; Maude SL; Levine JE; Pulsipher MA; Boyer MW; August KJ; Myers GD; Tam CS; Jaeger U; Foley SR; Borchmann P; Schuster SJ; Waller EK; Awasthi R; Potthoff B; Warren A; Waldron ER; McBlane F; Chassot-Agostinho A; Laetsch TW
Blood Adv; 2021 Dec; 5(23):4980-4991. PubMed ID: 34432863
[TBL] [Abstract][Full Text] [Related]
14. Systematic Profiling of
Huang YH; Chen CW; Sundaramurthy V; Słabicki M; Hao D; Watson CJ; Tovy A; Reyes JM; Dakhova O; Crovetti BR; Galonska C; Lee M; Brunetti L; Zhou Y; Tatton-Brown K; Huang Y; Cheng X; Meissner A; Valk PJM; Van Maldergem L; Sanders MA; Blundell JR; Li W; Ebert BL; Goodell MA
Cancer Discov; 2022 Jan; 12(1):220-235. PubMed ID: 34429321
[TBL] [Abstract][Full Text] [Related]
15. PAX5 haploinsufficiency induced CD8+ T cells dysfunction or exhaustion by high expression of immune inhibitory-related molecules.
Liang M; Gong D; Wang L; Liang X; Meng J; Huang W; Zhou J
Cancer Treat Res Commun; 2021; 28():100437. PubMed ID: 34425470
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S; Sakaguchi M; Oh I; Kako S; Toya T; Najima Y; Doki N; Kanda J; Kuroda J; Mori S; Satake A; Usuki K; Ueki T; Uoshima N; Kobayashi Y; Kawata E; Tajika K; Nagao Y; Shono K; Shibusawa M; Tadokoro J; Kayamori K; Hagihara M; Uchiyama H; Uchida N; Kubota Y; Kimura S; Nagoshi H; Ichinohe T; Kurosawa S; Motomura S; Hashimoto A; Muto H; Sato E; Ogata M; Mitsuhashi K; Ando J; Marumo A; Omori I; Fujiwara Y; Terada K; Yui S; Arai K; Kitano T; Miyata M; Kurosawa A; Mizoguchi A; Komatsu N; Fukuda T; Ohashi K; Kanda Y; Inokuchi K; Yamaguchi H
Blood Adv; 2022 Jan; 6(1):238-247. PubMed ID: 34448807
[TBL] [Abstract][Full Text] [Related]
17. The Genetics of Myelodysplastic Syndromes: Clinical Relevance.
Chiereghin C; Travaglino E; Zampini M; Saba E; Saitta C; Riva E; Bersanelli M; Della Porta MG
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440317
[TBL] [Abstract][Full Text] [Related]
18. Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Blombery P; Lew TE; Dengler MA; Thompson ER; Lin VS; Chen X; Nguyen T; Panigrahi A; Handunnetti SM; Carney DA; Westerman DA; Tam CS; Adams JM; Wei AH; Huang DCS; Seymour JF; Roberts AW; Anderson MA
Blood; 2022 Feb; 139(8):1198-1207. PubMed ID: 34469514
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
